News and Updates

A new nerve-repairing peptide therapy shows promising results in clinical trials, offering hope for functional recovery in spinal cord injury patients.

Researchers have launched a clinical trial testing new treatments for a challenging Ebola strain. Discover the impact on outbreak preparedness and care.

Discover how AI is revolutionizing oncology by enhancing surgical precision, accelerating drug discovery, and optimizing clinical trial designs for patients.

Bayer joins forces with CU Anschutz, UCHealth, and Children’s Hospital Colorado to accelerate drug development and expand access to critical clinical trials.

New Phase III trial data reveals that psilocybin therapy provides durable depression relief for six months, offering a breakthrough for treatment-resistance.

Increased US scrutiny of China-based clinical trials threatens to disrupt global drug development, forcing pharma firms to face rising costs and delays.

FibroBiologics achieves key milestone for CYWC628, a novel diabetic foot ulcer therapy, as it prepares for an upcoming Phase 1/2 clinical trial.

Despite $7 billion in funding, AI-driven drug discovery has yet to yield a single FDA-approved drug. Discover why the industry is shifting its strategy.

Anixa Biosciences has moved to the fifth cohort of its Phase 1 ovarian cancer vaccine trial, marking a key milestone in developing targeted immunotherapy.

Discover how agentic AI and real-world data are revolutionizing clinical trial design to accelerate drug development and enhance patient safety protocols.